Biosynthesis and metabolism of steroid hormones by human adrenal carcinomas.
Over a 15-year period, our university-based laboratory obtained 125 adrenal tumors, of which 15 (12%) were adrenal cortical carcinomas. Of these, 6 (40% of the carcinomas) occurred in patients with clear clinical manifestations of steroid hormone excess. Adrenal cortical carcinoma cells derived from the surgically resected tumors in 4 of these patients were isolated and established in primary culture. Radiotracer steroid interconversion studies were carried out with these cultures and also on mitochondria isolated from homogenized tissues. Large tumors had the lowest steroidogenic activities per weight, whereas small tumors had more moderately depressed enzyme activities relative to cells from normal glands. In incubations with pregnenolone as substrate, 1 mM metyrapone blocked the synthesis of corticosterone and cortisol and also the formation of aldosterone. Metyrapone inhibition was associated with a concomitant increase in the formation of androgens (androstenedione and testosterone) from pregnenolone. Administration of metyrapone in vivo before surgery in one patient resulted in a similar increase in plasma androstenedione, though plasma testosterone levels were not significantly affected. In cultures of two of four tumors examined, dibutyryl cAMP stimulated 11ss-hydroxylase activity modestly; ACTH also had a significant stimulatory effect in one of these tumors. Unlike results obtained with normal or adenomatous adrenal cortical tissues, mitochondria from carcinomatous cells showed a lack of support of either cholesterol side-chain cleavage enzyme complex or steroid 11ss-hydroxylase activity by Krebs cycle intermediates (10 mM isocitrate, succinate or malate). This finding is consistent with the concept that these carcinomas may tend to function predominantly in an anaerobic manner, rather than through the oxidation of Krebs cycle intermediates.
Brown
J W
JW
Adrenal Research Laboratory, Medical Research Service, VA Medical Center and Division of Endocrinology, Department of Medicine, University of Miami School of Medicine, Miami, FL 33125, USA. brown@rsmas.miami.edu
Fishman
L M
LM
D000305:Adrenal Cortex Hormones / Q000096:biosynthesis* / Q000302:isolation & purification / Q000378:metabolism; D000306:Adrenal Cortex Neoplasms / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000450:Aldosterone / Q000097:blood; D003994:Bucladesine / Q000494:pharmacology; D002277:Carcinoma / Q000378:metabolism*; D018929:Cell Culture Techniques; D002952:Citric Acid Cycle; D003900:Desoxycorticosterone / Q000378:metabolism; D006801:Humans; D008797:Metyrapone / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism; D011284:Pregnenolone / Q000378:metabolism; D013252:Steroid 11-beta-Hydroxylase / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D003900:Desoxycorticosterone; D000450:Aldosterone; D003994:Bucladesine; D011284:Pregnenolone; D000324:Adrenocorticotropic Hormone; D013252:Steroid 11-beta-Hydroxylase; D008797:Metyrapone